VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
Volition Veterinary Diagnostics Development LLC to Present Product Data Regarding its Nu.Q™ Vet Cancer Screening Test at the 2020 VCS Virtual Annual Conference
VolitionRx Limited Announces Virtual Capital Markets Day 2020
VolitionRx Limited to Present at Conferences in September 2020
VolitionRx Limited Announces Second Quarter 2020 Financial Results and Business Update
VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update
Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test
VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes
Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock